C O V E R S T O R Y
and climate change . However , with the BioE3 policy , we have established that India ' s economy will continue to grow by increasingly relying on living systems that work in harmony with the environment , rather than causing harm . From an industrial standpoint , we now have responsible guidelines on how to achieve sustainable growth .”
Bio-RIDE scheme lays thrust on biomanufacturing
The Union Cabinet approved the continuation of two umbrella schemes and Development ( R & D ), Industrial and Entrepreneurship Development ( I & ED ), and a newly introduced component focusing on Biomanufacturing and Biofoundry . Bio-RIDE is designed to foster innovation , promote bioentrepreneurship , and accelerate the commercialization of bio-based products and technologies .
Challenges
While the policy has been widely praised for its ambition , challenges remain . Industry leaders have raised
Bio-RIDE Scheme
• Promote Bio-Entrepreneurship
• Advance Innovation :
• Facilitate Industry-Academia Collaboration
• Encourage Sustainable Biomanufacturing
• Support researchers through Extramural funding
• Nurturing Human Resource in Biotechnology sector
from the Department of Biotechnology ( DBT ) under a unified program called the Biotechnology Research Innovation and Entrepreneurship Development ( Bio-RIDE ) scheme . With a financial outlay of Rs . 9,197 crore for the 15th Finance Commission period ( 2021-22 to 2025-26 ), the Bio-RIDE scheme aims to strengthen India ' s position as a global leader in biomanufacturing and biotechnology .
The scheme includes three major components : Biotechnology Research concerns over the potential costs of transitioning to bio-based systems , particularly for small and mediumsized enterprises ( SMEs ).
One of the primary challenges lies in the interdisciplinary nature of biotechnology . BIOE3 covers sectors such as healthcare , agriculture , environmental science , and biomanufacturing . Without a clear strategy for interdisciplinary collaboration , overlapping mandates and fragmented decision-making may
20
BioVoiceNews | October 2024